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ABSTRACT: The NBOMe derivatives are phenethylamines derived from the 2C class of hallucinogens. Only a few human phar-
macologic studies have been conducted on these drugs and several cases of intoxication and deaths have been reported. Presently, 
NBOMe are not a part of the routine drugs-of-abuse screening procedure for many police forces and there are no rapid immunoassay 
screening tests that can detect the presence of those compounds. In this paper, the voltammetric behavior of 25B NBOMe and 25I 
NBOMe were investigated and their electroanalytical characteristics determined for the first time. A novel, fast and sensitive screen-
ing method for the identification of the two most common NBOMes (25B-NBOMe and 25I-NBOMe) in real samples is reported. 
The method uses the electrochemical oxidation of these molecules to produce an analytical signal that can be related to the NBOMe 
concentration with an average lower limit of quantitation of 0.01mg/mL for both of them. The method is selective enough to identify 
the two compounds individually, even given the great similarity in their structure. 
INTRODUCTION 
The use of Novel Psychoactive Substances (NPS) has rapidly 
grown in the last years and reports of the availability and man-
ufacture of such substances increased. Those designer drugs are 
proliferating at an unprecedented rate and posing significant 
public health challenges 1. The number of NPS reported world-
wide rose from 126 in 2009 to 450 in 2014. In Europe the situ-
ation is even worse with a 7-fold increase in NPS seizures from 
2008 to 2013 2,3. 
Worldwide, from 2008 to 2013, seventeen percent of the total 
NPS reported to UNODC by countries were phenethylamines. 
In Europe phenethylamines represented 20% of the reports of 
new and existing NPS in 2013 and the second most abundant 
class of substances. The same happened in South America, Cen-
tral America and the Caribbean where phenethylamines reports 
reached 26% of the cases. In USA and Canada phenethylamines 
posed as the third group of substances most reported 4. Moreo-
ver a recent study exploring the patterns on drug use pointed 
specifically at NBOMe as the major NPS group reported as the 
most tried new drug 5. In the Brazilian Federal District the num-
ber of blotter paper seizures raised from 2 in 2012 to 70 in 2015 
with NBOMe compounds present in 85,5% of the cases (un-
published data). 
The NBOMe compounds are N-benzylmethoxy derivatives 
of the 2C family of hallucinogens with methoxy substitutions at 
positions 2 and 5 and a substitution at position 4, often consist-
ing of a halogen (i.e., chlorine, bromine, or iodine) 6–8. Those 
compounds are potent agonists of the human 5HT2A receptor, 
responsible for subjective and behavioral effects 7,8.They were 
mentioned for the first time in the book PIHKAL (1991)9. Alt-
hough human consumption appears to have begun in 2010, it 
has increased rapidly as a consequence of the easy availability 
through the internet 5. 
Scientific data regarding NBOMe compounds are very 
scarce. Only a few pharmacologic studies on humans have been 
conducted on these drugs. Reports of adverse effects after in-
gestion began to appear in the scientific literature in 2013, de-
scribing prominent neuropsychiatric effects and instability 6,10–
16. In severe cases death can occur even after ingesting a single 
dose 14. Despite the fact that they are very similar to one another, 
25I-NBOMe (2-(4-iodo-2,5-dimetoxifenil)-N-[(2 metoxi-
fenil)metil]etanamina) appears to be much more commonly re-
ported followed by 25B-NBOMe (2-(4-bromo-2,5-dimethoxy-
phenyl)-N-[(2-methoxyphenyl)methyl] ethanamine) 17,18. 
A routine standardized test on NBOMe compounds is not 
available in most forensic and clinical toxicology laboratories 
19. Laboratory-based analysis of NBOMEs compounds have 
been published by a few groups using chromatography, includ-
ing GC/MS, for seized material and LC/MS, HPLC/MS for 
blood, urine and serum samples. The first fully validated 
method to detect NBOMe compounds in seized material was 
reported by Casale and Hays (2012), using GC/MS, although 
the mass spectra obtained from 25B-NBOME, 25C-NBOMe 
and 25I-NBOMe are very similar with the three main ions co-
incident, being necessary ratios calculation or the use of a com-
plimentary technique such as FTIR for final determination. 
Zuba (2013) 7 also described the analytical properties of 25C-
NBOMe in seized samples using GC/EI/MS with and without 
derivatization, LC/QTOF/MS, FTIR and NMR. More recently, 
the use of ATR-FTIR combined with chemometric discriminant 
analysis were described for detecting illicit substances like 
NBOMEs compounds and other NPS directly from seized paper 
 blotters 20. Polkis (2015) 21 also described the detection of 
NBOMe compounds in blotter papers by DART-MS, confirmed 
by HLPC MS-MS. 
Toxicology analyses were performed mostly in individual 
case reports using LC/MS/MS, HLPC/MS/MS and 
LC/QTOF/MS. Rose et al. (2013) 10 described the first case re-
port with quantification of 25I-NBOMe compound in serum us-
ing HPLC/MS/MS. Shortly after, a validated method was de-
scribed by the same group 22. Validated methods for quantifica-
tion of NBOMe compounds including 25B-NBOMe and 25C-
NBOMe in body fluids such as serum, urine and blood, were 
lately described using HPLC/MS/MS, LC/MS/MS and 
UPLC/MS/MS 6,11,13,16,21,23. The limit of detection varies, reach-
ing as low as 10 pg/mL 10,21. 
Presently, NBOMe are not a part of routine drugs-of-abuse 
screening and there are no rapid color screening tests or point-
of-care devices that can quickly detect them 11. Just a few com-
mercial reference laboratories offer a qualitative test to identify 
those compounds 12. 
Due to the scenario presented the development and improve-
ment of a specific and appropriate analytical method to rapid 
detect and quantify NBOMes compounds is urgent. In this arti-
cle we present an electrochemical method for detection of 25B-
NBOMe and 25I-NBOMe that is cost effective, portable and 
exhibits high sensitivity and selectivity towards the target ana-
lytes. 
EXPERIMENTAL SECTION 
Materials. All reagents used were analytical grade from Sigma Al-
drich (Gillingham, UK). Deionised water (resistivity>16 cm) was 
used throughout all the experiments. 0.2 M PBS buffer was used as 
supporting electrolyte. Certified standards of 25B NBOMe, 25I 
NBOMe and 2C-B were also purchased from Sigma-Aldrich 
(Cerilliant). Blotter papers were seized by the Federal District Civil 
Police in Brazil between the years 2014 and 2015. 
Instruments. GC-MS analysis were performed using Perkin 
Elmer® Clarus®500 GC interfaced to Clarus®500 GC mass spec-
trometer using quadrupole mass analyzer. The system was con-
trolled with PerkinElmer® TurboMass™ GC/MS Software version 
5.4.2.1617. All electrochemistry experiments and measurements 
were performed using a portable bipotentiostat/galvanostat µstat 
400 (Dropsense, Oviedo, Spain) connected to a personal computer 
(Dell Vostro, Windows 7, Dell, Round Rock, TX, USA) using 
Dropview 8400 software (Dropsense). Experiments were per-
formed using screen-printed glassy carbon electrodes (DRP-150 - 
WE carbon, CE platinum, RE silver) with 3mm working area pur-
chased from Dropsense. Raman analysis were perfomed in a 
Horiba® LapRAM® HR-UV Spectrometer controlled with Lab-
Spec™ software version 5.93.20.  
Methods. Street samples extraction was carried out with no pre-
treatment and at room temperature as follow. One blotter paper was 
placed in an Eppendorf tube and 1mL of PBS was added. The tube 
was then gently mixed to extract th NBOMes. The DPV analysis 
was carried immediately by adding 50 L of the resulted mixture 
to the electrode. GC-MS method was adapted from previously de-
scribed methods7,24. Cyclic Voltametry (CV) was performed using 
a potential range from -0.2 V to +1.4 V, step potential 0.01 V and 
scan rate 0.1 V/s. Differential Pulse Voltammetry (DPV) was per-
formed using a potential range from -0.1 V to +1.4 V, step potential 
0.01 V, pulse potential 0.02 V, scan rate 0.1 V/s and pulse time 10 
ms. 
RESULTS AND DISCUSSION 
Electrochemical characterization of 25B NBOMe and 25I 
NBOMe. The investigation of the electrochemical behavior by cy-
clic voltammetry using a carbon screen-printed electrode showed 
two oxidative waves observed at +1.04 V and +1.25 V for 25B-
NBOMe and +1.02 V and +1.21 V for 25I-NBOMe. A single re-
duction wave was also observed at +0.06 V for both compounds. It 
is worth noting that the second anodic wave (peak II in Figure 1) 
only appeared when the anodic scan was performed to potentials 
up to or beyond +1.4 V and induced the appearance of the reduction 
wave (peak III in Figure 1). Moreover, if a second sequential scan 
was performed using the same electrode, it was also possible to ob-
serve a third oxidation peak at lower potential, Ep=+0.12 V (peak 
IV, Figure 1). 
The difference measured between the peak potential Ep (mV) and 
the potential at half peak height Ep/2 of the first anodik peak (peak 
I in Figure 1) was 50 mV. This value for Ep-Ep/2 is compatible with 
a monoelectronic electron transfer. In this case it is likely that peak 
I is a result of the electrochemical oxidation of the secondary amine 
present in the NBOMe molecule. Moreover the oxidation potentials 
observed are similar to those previously described in the literature 
for other similar compounds containing secondary amines 25–27. 
The oxidation of the secondary amine (peak I) involves a removal 
of an electron of the amino-nitrogen atom, leading to the formation 
of a primary amine which will be attached to the electrode and an 
aldehyde and likely free primary amine once the latter reached sat-
uration on the SPCE surface (Figure 1). 
The second anodic peak (peak II) is a result of the replacement of 
the halogen present in the NBOMe compounds by an hydroxyl 
group to further produce a ketone. The generally accepted mecha-
nistic for alkyl iodides and bromides, suggests an initial electron 
transfer from the highest filled molecular orbital of the organic hal-
ide to the electrode. In subsequent steps, the cation radical [RX]+• 
may undergo fission of the carbon-halogen bond to form carbo-
cations and oxidizable halogen, or a nucleophilic attack (e.g. by the 
solvent) via SN2 type displacement28. 
Peak III is dependent on peak II occurrence, as previously men-
tioned. Furthermore, the occurrence of peak IV, present if a second 
scan is performed in the same electrode, resemble typical qui-
none/catechol interconversions (Figure 1). The presence of this re-
dox couple suggests interaction of the NBOMe products with the 
electrode surface at the higher potentials. If further scans are per-
formed in the voltammetric analysis a decrease in the amine oxida-
tion peak (I) and a progressive increase in the current correspond-
ing to redox couple (III/IV) can be noticed. This feature has been 
previously described during electrochemical grafting experiments 
and constitutes a clear indication of such a reaction26. Also, the ap-
parition of a redox couples by interaction of electroactives com-
pounds at high potentials are typical in carbon electrodes 29. 
To verify the hypothesis, that the second oxidation peak (peak II) 
is due to the halogen oxidation to a hydroxyl group and subsequent 
oxidation to a ketone (quinone/catechol equilibrium), the electro-
chemical analysis of 2,5-dimethoxy-4-bromophenethylamine (2C-
B) was performed. This compound was chosen as it presents a very 
similar structure to the 25B NBOMe although it presents a primary 
amine and therefore an aromatic ring is absent (Figure 2). 
 Figure 1. Cyclic voltammetry profiles obtained using a screen-printed carbon electrode in 0.05 mg/mL 25I NBOMe aqueous solution at pH 
7 in 0.2 M PBS. Scan rate 0.1 V/s. First scan is represented as a solid line, second scan as a dashed line. 
The voltammogram obtained in this analysis showed just one oxi-
dation peak (Ep= +1.21 V) at nearly the same potential of the sec-
ond oxidation peak (peak II in Figure 1) of the 25B-NBOMe (Fig-
ure 3). This corresponds to the fact that 2C-B is similar in structure 
and just contains as an oxidation site at low potentials the same 
halogen atom, since the oxidation of the primary amine in 2C-B 
occurs at much higher potentials than the potential range applied in 
our experiments 26. 
The oxidation of phenethylamines as codeine, MDA and MDMA 
is complex27,30,31. MDA electrochemical studies are controversial 
as some authors show that MDA can undergo oxidation 30 while 
others stands the opposite 27. MDMA oxidation show two anodic 
peaks and involves the removal of an electron from the amino-ni-
trogen atom, leading to the formation of a primary amine and an 
aldehyde 27. The oxidation study of 2-methoxy amphetamine sug-
gests that the anodic process observed in the second anodic peak in 
MDMA compounds does not involve the amine-substituted side 
chain or the aromatic ring rather involve 3,4-methylenedioxy- sub-
stituted benzene ring 30, configuring a different process that the one 
proposed by us. 
 
Figure 2. Chemical structure of 25B-NBOMe, 25I-NBOMe and 
2C-B. 
In order to confirm that the voltammetric scans were leading to the 
attachment of an organic group to the surface of the carbon elec-
trode, Raman analyses were performed on the electrode surface af-
ter rinsing. 
A strong raman signal around 1580 cm-1, suggesting the presence 
of an aromatic ring attached to the electrode surface (Figure 4) 32 
was observed. This seems to indicate that the linkage process ini-
tially developed via a one-electron oxidation of the amine group to 
its corresponding cation radical, which subsequently forms a car-
bon-nitrogen bond with the carbon surface. The covalent attach-
ment of aliphatic amines is well known in the literature. Just a few 
aromatic amines demonstrate the ability to link covalently to the 
carbon surface as the aromatic ring blocks the surface binding sites 
promoting a low coverage of the modified electrode 26,33–35. 
The effect of scan rate (v) on the peak current (ip) and the peak 
potential (Ep) upon the electrochemical oxidation of 25B-NBOMe 
and 25I-NBOMe were examined in a 0.05 mg/mL solution at pH 7. 
A linear relationship was observed between log ip and log v corre-
sponding to the equations: log ip (I) = 0.63±0.01 log v +2.20 ± 0.01 
for 25B-NBOMe and log ip (I) = 0.53 ± 0.03 log v +2.00 ±0.04 for 
25I-NBOMe where v is in mVs-1. The slope of 0.63 and 0.53 is 
close enough to the theoretically expected value of 0.5 for a purely 
diffusion-controlled current36. We have observed only small 
changes in the peak potential of peak I and never observed a reduc-
tion peak in the cathodic direction associate with peak I in the cy-
clic voltammograms at higher scan rate. This behavior suggests that 
the process follows a scheme EC with fast chemical reaction. On 
the other hand, the current intensity corresponding to redox couple 
III/IV increases with the scan rate in a linear form with vx where x 
 is close to 0.75 indicating that the kinetic control is a mixture of 
diffusion and adsorption processes in a good agreement with the 
production of covalent attachment and free oxidized forms of 
NBOMe molecules on carbon electrode. 
The effect of the pH versus the electrochemical signal of the 25B-
NBOMe and 25I-NBOMe was also studied. DPV voltammograms 
were obtained in a potential range from -0.2 to +1.4 V in 0.05 
mg/mL 25B NBOMe/25I NBOMe solutions in a pH range from 5.0 
to 11.0. The linear relationship of Ep1 vs. pH revealed a slope of 
−46.0 and -51.0 mV/pH for 25B NBOMe and 25I NBOMe, respec-
tively (Figure 5). This indicates that the proton transfer in the elec-
troactive groups of the NBOMe compounds affects the overall elec-
trode reaction mechanism as it has been indicated in the reactions 
of the Figure 1. 
The linear relationship of Ep1 vs. pH revealed a slope of −46.0 and 
-51.0 mV/pH for 25B NBOMe and 25I NBOMe, respectively (Fig-
ure 5), indicating an irreversible reaction mechanism, involving the 
same number of protons and electrons in the process 37. Those 
slopes are in the order of magnitude to that expected for a monoe-
lectronic/monoprotonic reaction (59.2 mV/pH at 25 °C) 38.
For values of pH between 5.0 and 11.0, the peak potential Ep2 is pH 
independent, for 25B NBOMe and 25I NBOMe indicating that, in 
this pH range, the peak potential is not affected by the concentra-
tion of H+. 
Electroanalytical determination of 25B-NBOMe and 25I-
NBOMe. Once the electrochemical mechanism and the optimal pH 
conditions for analysis were defined differential pulse voltammetry 
was attempted. Figure 6 shows both oxidation waves at the same 
potentials than those observed in CV for both compounds. The an-
alytical identification for 25B-NBOMe and 25I-NBOMe was per-
formed using the second oxidation wave, although the first oxida-
tion wave was used in the quantification analysis. The method was 
optimized regarding peak height and reproducibility and optimum 
instrumental parameters used in DPV were chosen studying varia-
tion in step potential, pulse potential, number of scans and pulse 
time. 
To evaluate the analytical performance of the method the main pa-
rameters analyzed were stability, linearity, sensitivity, precision 
and trueness (accuracy), selectivity, robustness and ruddgeness. 
 
 
Figure 3. Ciclic voltammetric profiles obtained at a screen-printed carbon electrode in a solution with 0.05 mg/mL of 25B NBOMe (dotted 
line) and 2C-B (solid line) in a pH7 PBS buffer. Scan rate 0.1 V/s. 
 Figure 4. Raman spectra of a blank screen-printed carbon electrode (blue line), after 10 CV scans of a solution containing 25I-NBOMe 
(green line) and 25B-NBOMe (red line). 
Figure 5. Influence of pH on the peak I potential of a 0.05 mg/mL 
25B NBOMe solution (■) and 25I NBOMe (♦) solution dissolved 
in PBS by DPV. Scan rate 0.1 V/s. 
To measure stability, the standard stock solution, stowed in the dark 
at -4oC was used in the period over 6 months and no changes were 
observed in peak potential or peak current. The standards work so-
lutions were prepared daily with PBS at pH 7.0. 
An eight-point calibration graph in the range 0.01mg/mL – 0.08 
mg/mL, n= 5, were used to verify method linearity and sensitivity. 
The peak current was found to be directly proportional to the drug 
concentration in all concentration range analyzed. The detectability 
of the developed method was checked in terms of limit of detection 
(LOD) and limit of quantification (LOQ) values. Table 1 summa-
rizes the data from the main calibration curve, statistical evaluation 
of the regression lines and the analytical characteristics of the 
method. 
The precision and ruggedness of the proposed method was investi-
gated with respect of repeatability and reproducibility considering 
peak potential and peak current for both oxidation peaks, I and II, 
as the first peak is important regarding quantification and the sec-
ond peak is important for identification purposes. The repeatability 
was evaluated from 5 repeated measurements of the electrochemi-
cal signal of 0.05 mg/mL 25B NBOMe and 25I NBOMe solutions 
under optimal conditions. The mean measured potential for peak I 
was +1.040 ±0.001 V for 25B NBOMe and +1.020 ±0.010 V for 
25I NBOMe and for peak II +1.250 V ±0.006 V for 25B-NBOMe 
and +1.210 ±0.010 V for 25INBOMe. Intraday and inter-day pre-
cisions were evaluated after analysis of three concentrations chosen 
from low, medium and high concentration levels (0.025 mg/mL, 
0.042 mg/mL and 0.072 mg/mL) in the linear range. Every sample 
in each series was analyzed three times under optimal conditions 
over 3 consecutive days. Precision was expressed as the relative 
standard deviation (%RSD) in table 1. Trueness was determined by 
comparing the calculated mean concentrations and experimental 
concentrations values and expressed as a percentage relative error 
(bias %). 
The robustness of the method was tested by evaluating peak I po-
tential and current by introducing known changes in the experi-
mental parameters such as pH (7.0 – 7.3) and supporting electro-
lites (0.18 - 0.2M). Only one parameter was changed at a time. 
These parameters were evaluated for a 0.05mg/mL solution of 25B 
NBOMe/25I NBOMe (Table 2). A Friedman test was used for sta-
tistical comparison and did not detect any differences across multi-
ple test attempts (p = 0.13 ˃ p=0.05). No statistically significant 
changes were found neither in peak current or peak potential. 
 Figure 6. Differential pulse voltammetric profiles obtained at a screen-printed carbon electrode in a solution with 0.05 mg/mL of 25B 
NBOMe (solid line) and 25I-NBOMe (dotted line) in a pH7 PBS buffer. Scan rate 0.1 V/s. 
 
 
25B NBOMe 25I NBOMe 
regression equation a y=(96±4)x+1.4±0.2 y=(122±6)x+3.0±0.3 
correlation coefficient (R2) 0.991 0.996 
standard error of the slope (mV) 3.57 5.60 
standard error of the intercept (mV)  0.18 0.28 
linearity range (mg/mL) 0.01 - 0.08 0.01 - 0.08 
Calibration graph (n=5) 
    
LOD (mg/mL) 0.011 0.004 
LOQ (mg/mL) 0.034 0.012 
accuracy (mg/mL) (RSD) 1.85% 0.66% 
 
peak I peak II peak I peak II 
Intraday precision (n=5)b 
    
peak potential (V) 2.2% 2.0% 1.0% 0.93% 
peak current (A) 4.4% 2.4% 3.5% 1.8% 
     
Inter-day precision (n=5)b 
    
peak potential (V) 2.8% 2.3% 1.3% 1.0% 
peak current (A) 7.9% 5.6% 3.6% 2.3% 
Table 1. Analytical parameters for the quantitative determination of 25B NBOMe and 25I NBOMe using the DPV. A y = bx+a; x = concen-
tration (mg/mL), y = peak current (V), a = intercept, b=slope. 
  
 25B NBOMe 25I NBOMe 
 Peak Potetial (V) Concentration found Peak Potetial (V) Concentration found 
pH mean ± SD RSD% mg/mL RSD % mean ± SD RSD% mg/mL RSD % 
7.0 1.040 ± 0.006 0.58 0.049 ± 0.006 0.48 1.02 ± 0.06 0.58 0.049 ± 0.004 0.68 
7.1 1.040 ± 0.006 0.59 0.053 ± 0.008 0.81 1.02 ± 0.06 0.56 0.049 ± 0.006 0.78 
7.2 1.03 ± 0.01 1.01 0.048 ± 0.009 1.11 1.01 ± 0.01 1.02 0.042 ± 0.008 1.22 
Concentration         
0.2M 1.040 ± 0.006 0.57 0.059 ± 0.007 0.75 1.02 ± 0.06 0.58 0.047 ± 0.002 0.37 
0.19M 1.03 ± 0.01 1.00 0.06 ± 0.01 1.21 1.03 ± 0.01 1.00 0.045 ± 0.005 0.61 
0.18M 1.040 ± 0.006 0.58 0.057 ±  0.009 0.83 1.02 ± 0.06 0.58 0.045 ± 0.004 0.49 
Table 2. Robustness data for the DPV method developed in the present study for determination fo 25B NBOMe and 25I NBOMe. 
 
Analytical application. A validation study was performed using 
GC-MS as the reference method. A nine point concentration set 
was elaborated from 0.015 to 0.075 mg/mL and the experimental 
value observed by the voltammetric method was compared against 
the reference method in triplicate. A linear regression based on 
peak height (A) of peak I (Figure 1), showed a correlation coeffi-
cient (R2) of 0.9944 (y = 1.03 ± 0.01 x – 0.0023 ± 0.0009) and the 
average error was 0.38% for 25B NBOMe and was 0.07% for 25I 
NBOMe, demonstrating a strength relation between the two meth-
ods. Uncertainty, measured as 3 times the standard deviation was 
0.15% for low concentration points, 0.04% for mid concentration 
points and 0.09% for upper concentration points (Figure 7) 
Analysis of real street samples. To complete the analytical vali-
dation and to prove its usefulness in analyzing real street samples, 
20 paper blotters seized by the Federal District Civil Police in Bra-
zil between the years 2014 and 2015, containing 25B NBOMe 
(n=13) and 25I NBOMe (n=7) were analyzed using the voltammet-
ric method described in this study. DPV results were compared 
with GC/MS data for both identification and quantification pur-
poses. 
DPV was able to correctly identify the presence of the 25B NBOMe 
or/and 25I NBOMe in 82% of the samples analysed, allowing the 
rapid identification of the NBOMe compounds present in the paper 
blotters. Quantification analysis showed an average calculated er-
ror of 0.005 mg/mL and RSD% 3.99 for 25B NBOMe and 0.005 
mg/mL and RSD% of 5.08 for 25I NBOMe between both methods. 
A paired-samples t-test was conducted to test the hypothesis that 
the results obtained in the analysis using Dropsens and GC-MS 
were equal. There was no significant difference in the measure-
ments taken by Dropsens (25B NBOMe M = 0,0446, SD = 
0,000417; 25I NBOMe M = 0,0436, SD = 0,000385) and GC-MS 
(25B NBOMe M = 0,0454, SD = 0,000385; 25I NBOMe M = 
0,0440, SD = 0,000363); 25B NBOMe, t (8) = 1.07, p = 0.31; 25I 
NBOMe t (8) = 1.21, p = 026, demonstrating the suitability of the 
proposed method as a quick screening method for forensic samples. 
.
Figure 7. Comparison of concentration values obtain in the experi-
mental set with GC/MS and DPV (n=3 for each concentration). 25B 
NBOMe (♦) and 25I NBOMe (♦). 
CONCLUSIONS 
For the first time the voltammetric behavior of phenethylamines 
such as 25B-NBOMe and 25I-NBOMe was investigated and the 
mechanism and analytical characteristics determined. The oxida-
tion of the secondary amine present in the NBOMe compounds pro-
duced a covalent link to the electrode. This was also confirmed by 
Raman spectroscopy. The electroanalytical method has good spec-
ificity and sensitivity and LOD, LOQ, linear range and precision 
demonstrated the method to be analytically valuable. The analyses 
of real forensic samples also proved that the method can be of use 
as screening method to support a number of others analytical ap-
proaches, as it is quick, portable and can be carried out in the field. 
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